Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Andreae-Noris Zahn has signed a share purchase agreement to acquire a 92% stake in Lithuania-based pharmaceutical wholesaler JSC Armila.
Subscribe to our email newsletter
Following recent acquisitions in Croatia and Romania, the purchase of Armila is said to represent the latest stage in Anzag’s strategy to establish itself in carefully targeted high-growth markets.
Thomas Trumper, chairman of the board at Anzag, said: “By acquiring Armila, we are expanding our business in foreign markets, and so reducing our dependency on our home market of Germany, and our vulnerability to cyclical fluctuations here.”